Joined Today: 2

BIIB Biogen Idec, Stock Message Board

All Messages

BIIB Message Board Home | Join The BIIB Group |

#129: BIIB News Biogen Idec Initiates Phase III Clinical Program of Oral Compound BG-12 for Multiple Sclerosis
Stock News Bot	January 9, 2007 06:00:00 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB) announced today that it has initiated the Phase III clinical program of BG-12, an oral fumarate in development for ... view message ignore post recommend post

#128: BIIB News Elan and Biogen Idec Submit Supplemental Biologics License Application to the FDA for the Approval of TYSABRI(R) as a Treatment for Crohn's Disease
Stock News Bot	December 15, 2006 06:10:00 AM
DUBLIN, Ireland & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Elan Corporation, plc (NYSE: ELN) and Biogen Idec (NASDAQ: BIIB) announced today the submission of a supplemental Biologics License ... view message ignore post recommend post

#127: BIIB News Phase I/II Data Support Continued Development of Biogen Idec's Novel Anti-CD23 Antibody for Chronic Lymphocytic Leukemia
Stock News Bot	December 10, 2006 03:00:00 PM
ORLANDO, Fla.--(BUSINESS WIRE)--Biogen Idec (Nasdaq: BIIB) announced data from a Phase I/II study of an investigational anti-CD23 monoclonal antibody, lumiliximab, suggesting it may... view message ignore post recommend post

#126: BIIB News Biogen Idec to Present at the 2006 RBC Capital Markets Healthcare Conference
Stock News Bot	December 7, 2006 07:49:00 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ/BIIB) announced today that its presentation at the 2006 RBC Capital Markets Healthcare Conference will be webcast live via... view message ignore post recommend post

#125: BIIB News Biogen Idec to Present at the Lazard Capital Markets Third Annual Life Sciences Conference
Stock News Bot	November 20, 2006 12:45:00 PM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ/BIIB) announced today that its presentation at the Lazard Capital Markets Third Annual Life Sciences Conference will be ... view message ignore post recommend post

#124: BIIB News Biogen Idec to Present at the Credit Suisse 2006 Healthcare Conference
Stock News Bot	November 8, 2006 07:48:00 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ:BIIB) announced today that its presentation at the Credit Suisse 2006 Healthcare Conference will be webcast live via the... view message ignore post recommend post

#123: BIIB News AVONEX(R), the Most Prescribed Multiple Sclerosis Therapy Worldwide, Launched in Japan
Stock News Bot	November 8, 2006 05:30:00 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB) announced today that AVONEX® (Interferon beta-1a), the most prescribed multiple sclerosis (MS) therapy worldwide, is... view message ignore post recommend post

#122: BIIB News Biogen Idec to Present at the Cowen & Company 7th Annual Global Healthcare Conference
Stock News Bot	October 31, 2006 11:49:00 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ:BIIB) announced today that its presentation at the Cowen & Company 7th Annual Global Healthcare Conference will be... view message ignore post recommend post

#121: BIIB News Biogen Idec to Present at the CIBC World Markets 17th Annual Healthcare Conference
Stock News Bot	October 31, 2006 09:19:00 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ:BIIB) announced today that its presentation at the CIBC World Markets 17th Annual Healthcare Conference will be webcast... view message ignore post recommend post

#120: BIIB News Biogen Idec to Present at the Rodman & Renshaw 8th Annual Healthcare Conference
Stock News Bot	October 31, 2006 09:11:00 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ:BIIB) announced today that its presentation at the Rodman & Renshaw 8th Annual Healthcare Conference will be webcast... view message ignore post recommend post

#119: BIIB News Biogen Idec Reports Third Quarter 2006 Results
Stock News Bot	October 31, 2006 04:18:00 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ: BIIB), a global biotechnology company with leading products and capabilities in oncology, neurology and immunology, today... view message ignore post recommend post

#118: BIIB News TYSABRI(R) Maintained Remission in Patients with Moderate-to-Severe Crohn's Disease Treated for Longer Than Two Years According to Data Presented This Week
Stock News Bot	October 24, 2006 05:00:00 AM
DUBLIN, Ireland & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Elan Corporation, plc (NYSE:ELN) and Biogen Idec (NASDAQ:BIIB) announced today data that show TYSABRI® (natalizumab)... view message ignore post recommend post

#117: BIIB News Biogen Idec To Report Third Quarter 2006 Financial Results on October 31, 2006
Stock News Bot	October 23, 2006 05:59:00 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (Nasdaq:BIIB) today announced it will report third quarter 2006 financial results on Tuesday, October 31, 2006, before the ... view message ignore post recommend post

#116: BIIB News Biogen Idec Named Top Employer by Science Magazine
Stock News Bot	October 19, 2006 11:01:00 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB), a global biotechnology leader with products and capabilities in oncology, neurology and immunology, has been named a ... view message ignore post recommend post

#115: BIIB News New Pharmacoeconomic Data on TYSABRI(R) Demonstrate Significant Reduction in Steroid Use and Hospitalizations in Patients with Multiple Sclerosis
Stock News Bot	October 6, 2006 06:00:00 AM
CAMBRIDGE, Mass. & DUBLIN, Ireland--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced that data to be presented today at the Academy of Managed Care... view message ignore post recommend post

Group Home | Login if you want to post a message